News from Zyme and the companies we work with.
Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits
Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, [...]
BioTrinity 2025: Over 800 Professionals Convene to Paint a Picture of Hope for UK Life Sciences
BioTrinity 2025 welcomed over 800 delegates, matching the highest-ever attendance set in 2024. Three action-packed tracks covered investment trends, regulatory shifts, and cutting-edge scientific advancements. Nearly 10,000 meetings requested, with [...]
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
Cambridge, UK, 02 April 2025 – 4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today [...]
Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection
First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of [...]
FairJourney Biologics establishes Supervisory Board
Werner Lanthaler appointed as Chair and joined by global industry leaders The Supervisory Board will define key avenues for growth, accelerate innovation, and optimize scientific strategies to maintain leadership in [...]
Owlstone Medical Announces Investment of up to $2.3 Million USD from the Cystic Fibrosis Foundation to Develop a Breath Test for Pseudomonas aeruginosa Detection in Cystic Fibrosis Patients
Test to be developed for Pseudomonas aeruginosa detection in patients with cystic fibrosis suitable for both detection of new cases and monitoring of chronic infection Support to demonstrate proof of [...]
US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies
London, UK, 24 March 2025: Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, today announced the expansion of its US patent portfolio. Strengthening its cardiometabolic treatment portfolio, the [...]
Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle Baltimore, MD, 19 March 2025 – Sapio Sciences, the science-aware™ lab informatics platform, today announced the [...]
SolasCure enrols first patient in a next Phase II clinical trial to advance Aurase Wound Gel
Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers Cambridge, UK 17 March 2025: [...]
Bio-Rad Launches XP-Design Assay Salmonella Serotyping Solution for Rapid and Accurate Food Safety Testing
HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of XP-Design Assay Salmonella [...]
H.E.L Group signs research agreement with the Institute of Chemical Technology (ICT) in Mumbai
Collaboration with ICT Mumbai will focus on advancing process safety and chemical synthesis in India London, UK, 12 March 2025: H.E.L Group (H.E.L), a global developer and manufacturer of innovative [...]
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium Pharmaceuticals Cambridge, UK, 12 March 2025: Shift [...]
